What is the clobetasol propionate (generic) equivalent of the brand medication Temovate?

Clobetasol Propionate is the Generic Equivalent of Temovate

Clobetasol propionate 0.05% is the generic formulation that is therapeutically equivalent to the brand name Temovate. 1

Key Information

Active Ingredient and Formulations

• Generic name: Clobetasol propionate
• Brand name: Temovate (and Temovate E Emollient)
• Standard concentration: 0.05%
• Available formulations: Cream, ointment, lotion, scalp application, foam, gel 2, 1

Classification and Potency

Clobetasol propionate is classified as a very high potency (Class 1) topical corticosteroid - the most potent category available 2, 3, 4. This ultrapotent classification applies to both the brand name Temovate and all generic clobetasol propionate 0.05% formulations.

Clinical Applications

Multiple guidelines consistently recommend clobetasol propionate 0.05% as first-line therapy for:

• Lichen sclerosus (anogenital and extragenital): Applied once daily initially, then tapered 5, 6, 5
• Bullous pemphigoid: 30-40 g daily for extensive disease, 10-20 g daily for localized disease 7
• Moderate to severe plaque psoriasis: Particularly for thick, chronic plaques 3, 8
• Scalp psoriasis: 81% clearance rate at 2 weeks versus 22% with vehicle 8, 9
• Atopic dermatitis: For severe disease and flares 10

Important Safety Considerations

HPA Axis Suppression Risk

Clobetasol propionate carries significant risk of hypothalamic-pituitary-adrenal (HPA) axis suppression 1:

• In psoriasis patients: 8 of 10 patients suppressed after 4 weeks of therapy
• In atopic dermatitis patients: 5 of 9 patients suppressed after just 2 weeks
• Recovery of adrenal function is generally prompt upon discontinuation, but some patients may have delayed recovery

Duration Limits

• Maximum 2 consecutive weeks for moderate to severe atopic dermatitis 1
• Maximum 4 consecutive weeks for moderate to severe plaque psoriasis 1
• Longer durations (up to 12 weeks) only under careful physician supervision 3

Application Restrictions

• Avoid use on face, groin, or axillae 1
• Do not use for rosacea or perioral dermatitis 1
• Use lower potency steroids for intertriginous areas and areas susceptible to atrophy 3

Bioequivalence Considerations

While clobetasol propionate is the generic equivalent, not all generic formulations demonstrate bioequivalence 11. A 2018 study evaluating 12 clobetasol propionate formulations found that only one generic showed no statistical difference from the reference product in skin penetration tests. This highlights that while the active ingredient is identical, formulation differences can affect drug delivery and clinical efficacy.

Different vehicles (cream, ointment, foam, scalp application) show varying bioavailability profiles 12. However, FDA-approved generic formulations of clobetasol propionate 0.05% in the same vehicle type as Temovate are considered therapeutically equivalent.

Common Adverse Effects

Local reactions include 1, 8:

• Burning or stinging (approximately 11% of patients)
• Skin atrophy with prolonged use
• Folliculitis
• Local irritation

Systemic effects are rare but include potential for Cushing's syndrome, hyperglycemia, and glucosuria with excessive use 1.